Article
Characterization of a novel complex BRAF mutation in a follicular variant papillary thyroid carcinoma.
European journal of endocrinology - 1 Jul 2008
Barzon Luisa, Masi Giulia, Boschin Isabella Merante, Lavezzo Enrico, Pacenti Monia, Casal Ide Eric, Toniato Antonio, Toppo Stefano, Palù Giorgio, Pelizzo Maria Rosa
Abstract excerpt
INTRODUCTION: Activating mutations of the BRAF oncogene are frequently detected in papillary thyroid carcinoma (PTC) and have been associated with a worse prognosis. The amino acid substitution V600E accounts for 90% of all oncogenic BRAF mutations and is typically detected in classic PTCs, whereas other less frequent BRAF mutations seem to be associated with other PTC histotypes. CASE: Screening for activating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
